The presence of insulin resistance and elevated pro-inflammatory cytokines (e.g., tumor necrosis factor-α) induce hepatic GH resistance (64), causing increases in GH and decreases in IGF-I levels (Table 1). Here, GH1 is linked to Insulin resistance.